vs
Side-by-side financial comparison of Applied Therapeutics, Inc. (APLT) and Laser Photonics Corp (LASE). Click either name above to swap in a different company.
Applied Therapeutics, Inc. is the larger business by last-quarter revenue ($1.0M vs $919.3K, roughly 1.1× Laser Photonics Corp). Laser Photonics Corp runs the higher net margin — -506.4% vs -1899.0%, a 1392.6% gap on every dollar of revenue. On growth, Applied Therapeutics, Inc. posted the faster year-over-year revenue change (719.7% vs 28.3%).
Relief Therapeutics is a Swiss biopharmaceutical company based in Geneva. The company focuses on developing drugs for serious diseases with few or no existing treatment options. Its lead compound, RLF-100, is a synthetic form of a natural peptide that protects the lung. The company was incorporated as Relief Therapeutics Holdings AG (RFLB.S) and listed on the SIX Swiss Exchange in 2016.
IPG Photonics Corporation is a manufacturer of fiber lasers. IPG Photonics developed and commercialized optical fiber lasers, which are used in a variety of applications including materials processing, medical applications and telecommunications. IPG has manufacturing facilities in the United States, Germany, Russia and Italy.
APLT vs LASE — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.0M | $919.3K |
| Net Profit | $-19.0M | $-4.7M |
| Gross Margin | — | -20.1% |
| Operating Margin | -1675.8% | -350.0% |
| Net Margin | -1899.0% | -506.4% |
| Revenue YoY | 719.7% | 28.3% |
| Net Profit YoY | 72.3% | -186.5% |
| EPS (diluted) | $-0.13 | $-0.27 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $1.0M | $919.3K | ||
| Q2 25 | $0 | $2.6M | ||
| Q1 25 | $0 | $2.3M | ||
| Q4 24 | $-1.0K | $1.3M | ||
| Q3 24 | — | $716.7K | ||
| Q2 24 | $144.0K | $623.4K | ||
| Q1 24 | $190.0K | $743.0K | ||
| Q4 23 | $-667.0K | $994.6K |
| Q3 25 | $-19.0M | $-4.7M | ||
| Q2 25 | $-21.3M | $-1.8M | ||
| Q1 25 | $-21.8M | $-1.7M | ||
| Q4 24 | $44.0M | $586.4K | ||
| Q3 24 | — | $-1.6M | ||
| Q2 24 | $2.9M | $-934.3K | ||
| Q1 24 | $-83.9M | $-545.7K | ||
| Q4 23 | $-37.7M | $-486.6K |
| Q3 25 | — | -20.1% | ||
| Q2 25 | — | 53.5% | ||
| Q1 25 | — | 49.8% | ||
| Q4 24 | — | 13.3% | ||
| Q3 24 | — | 85.0% | ||
| Q2 24 | — | 50.6% | ||
| Q1 24 | — | 51.9% | ||
| Q4 23 | — | 84.5% |
| Q3 25 | -1675.8% | -350.0% | ||
| Q2 25 | — | -37.0% | ||
| Q1 25 | — | -68.7% | ||
| Q4 24 | 3302300.0% | -255.1% | ||
| Q3 24 | — | -238.0% | ||
| Q2 24 | -14194.4% | -149.4% | ||
| Q1 24 | -11101.6% | -73.8% | ||
| Q4 23 | 3149.3% | -88.4% |
| Q3 25 | -1899.0% | -506.4% | ||
| Q2 25 | — | -68.3% | ||
| Q1 25 | — | -73.4% | ||
| Q4 24 | -4400700.0% | 45.7% | ||
| Q3 24 | — | -226.8% | ||
| Q2 24 | 2012.5% | -149.9% | ||
| Q1 24 | -44177.9% | -73.4% | ||
| Q4 23 | 5649.0% | -48.9% |
| Q3 25 | $-0.13 | $-0.27 | ||
| Q2 25 | $-0.15 | $-0.12 | ||
| Q1 25 | $-0.15 | $-0.12 | ||
| Q4 24 | $0.52 | $0.06 | ||
| Q3 24 | — | $-0.13 | ||
| Q2 24 | $-0.13 | $-0.09 | ||
| Q1 24 | $-0.67 | $-0.06 | ||
| Q4 23 | $-0.40 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $11.9M | $3.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-561.0K | $4.1M |
| Total Assets | $34.4M | $17.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $11.9M | $3.6M | ||
| Q2 25 | $30.4M | $78.5K | ||
| Q1 25 | $50.8M | $179.1K | ||
| Q4 24 | $79.4M | $533.9K | ||
| Q3 24 | — | $2.1M | ||
| Q2 24 | $122.2M | $2.7M | ||
| Q1 24 | $146.5M | $5.2M | ||
| Q4 23 | $49.9M | $6.2M |
| Q3 25 | $-561.0K | $4.1M | ||
| Q2 25 | $17.4M | $4.3M | ||
| Q1 25 | $36.7M | $6.8M | ||
| Q4 24 | $57.0M | $10.2M | ||
| Q3 24 | — | $9.7M | ||
| Q2 24 | $72.4M | $10.3M | ||
| Q1 24 | $67.3M | $12.4M | ||
| Q4 23 | $-17.1M | $13.9M |
| Q3 25 | $34.4M | $17.5M | ||
| Q2 25 | $37.3M | $14.9M | ||
| Q1 25 | $56.9M | $16.0M | ||
| Q4 24 | $86.7M | $17.2M | ||
| Q3 24 | — | $10.6M | ||
| Q2 24 | $127.8M | $11.1M | ||
| Q1 24 | $151.2M | $13.6M | ||
| Q4 23 | $54.8M | $15.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.4M | $763.1K |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $-18.4M | $763.1K | ||
| Q2 25 | $-20.3M | $-1.0M | ||
| Q1 25 | $-28.6M | $-1.2M | ||
| Q4 24 | $-19.5M | $-6.5M | ||
| Q3 24 | — | $632.7K | ||
| Q2 24 | $-22.6M | $-2.4M | ||
| Q1 24 | $-18.9M | $-866.3K | ||
| Q4 23 | $-17.0M | $-2.0M |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $589.6K | ||
| Q2 24 | — | $-2.4M | ||
| Q1 24 | — | $-1.0M | ||
| Q4 23 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 82.3% | ||
| Q2 24 | — | -388.0% | ||
| Q1 24 | — | -136.9% | ||
| Q4 23 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 6.0% | ||
| Q2 24 | — | 5.1% | ||
| Q1 24 | — | 20.3% | ||
| Q4 23 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -0.44× | -11.11× | ||
| Q3 24 | — | — | ||
| Q2 24 | -7.80× | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
